327 related articles for article (PubMed ID: 26308299)
1. Pharmacovigilance in Europe.
Johnson CL; Hutchinson JA
Transplantation; 2015 Aug; 99(8):1542-3. PubMed ID: 26308299
[No Abstract] [Full Text] [Related]
2. The reorganisation of European pharmacovigilance. Part 2. From spontaneous reports to agency reviews and decisions.
Prescrire Int; 2015 Feb; 24(157):50-4. PubMed ID: 25802924
[TBL] [Abstract][Full Text] [Related]
3. Encouraging spontaneous reporting of adverse effects.
Prescrire Int; 2015 Feb; 24(157):53. PubMed ID: 25802925
[TBL] [Abstract][Full Text] [Related]
4. EU pharmacovigilance regulatory requirements of anticancer biosimilar monoclonal antibodies.
Francescon S; Fornasier G; Baldo P
Int J Clin Pharm; 2018 Aug; 40(4):778-782. PubMed ID: 30094558
[TBL] [Abstract][Full Text] [Related]
5. Is pharmacovigilance of biologicals cost-effective?
Claus B
Int J Clin Pharm; 2018 Aug; 40(4):787-789. PubMed ID: 30051230
[TBL] [Abstract][Full Text] [Related]
6. [Adverse drug reaction - Definitions, risk factors and pharmacovigilance].
Krähenbühl S
Ther Umsch; 2015 Dec; 72(11-12):669-71. PubMed ID: 26654809
[TBL] [Abstract][Full Text] [Related]
7. Pharmacovigilance in China: development and challenges.
Zhao Y; Wang T; Li G; Sun S
Int J Clin Pharm; 2018 Aug; 40(4):823-831. PubMed ID: 30051225
[TBL] [Abstract][Full Text] [Related]
8. [Direct reporting by patients of adverse drug reactions in Spain].
Esther Salgueiro M; Jimeno FJ; Aguirre C; García M; Ordóñez L; Manso G
Farm Hosp; 2013; 37(1):65-71. PubMed ID: 23461502
[TBL] [Abstract][Full Text] [Related]
9. Fifty years of pharmacovigilance - Medicines safety and public health.
Laporte JR
Pharmacoepidemiol Drug Saf; 2016 Jun; 25(6):725-32. PubMed ID: 26799344
[No Abstract] [Full Text] [Related]
10. Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology.
Baldo P; Francescon S; Fornasier G
Int J Clin Pharm; 2018 Aug; 40(4):748-753. PubMed ID: 30094557
[TBL] [Abstract][Full Text] [Related]
11. Pharmacovigilance in developing countries (part I): importance and challenges.
Elshafie S; Zaghloul I; Roberti AM
Int J Clin Pharm; 2018 Aug; 40(4):758-763. PubMed ID: 29248988
[TBL] [Abstract][Full Text] [Related]
12. Pharmacovigilance in developing countries (part II): a path forward.
Elshafie S; Roberti AM; Zaghloul I
Int J Clin Pharm; 2018 Aug; 40(4):764-768. PubMed ID: 29322474
[TBL] [Abstract][Full Text] [Related]
13. [Editorial: adverse drug reactions].
Taegtmeyer AB
Ther Umsch; 2015 Dec; 72(11-12):667. PubMed ID: 26654808
[No Abstract] [Full Text] [Related]
14. [Understanding and reducing the risk of adverse drug reactions in pediatric patients].
Gotta V; van den Anker J; Pfister M
Ther Umsch; 2015 Dec; 72(11-12):679-86. PubMed ID: 26654811
[TBL] [Abstract][Full Text] [Related]
15. The Role of Disproportionality Analysis of Pharmacovigilance Databases in Safety Regulatory Actions: a Systematic Review.
Dias P; Penedones A; Alves C; Ribeiro CF; Marques FB
Curr Drug Saf; 2015; 10(3):234-50. PubMed ID: 26219291
[TBL] [Abstract][Full Text] [Related]
16. [From pharmacovigilance to pharmacoepidemiology and risk coordination].
Montastruc JL
Rev Med Interne; 2009 Dec; 30 Suppl 4():S281-90. PubMed ID: 19892443
[No Abstract] [Full Text] [Related]
17. The ISoP CommSIG for Improving Medicinal Product Risk Communication: A New Special Interest Group of the International Society of Pharmacovigilance.
Bahri P; Dodoo AN; Edwards BD; Edwards IR; Fermont I; Hagemann U; Hartigan-Go K; Hugman B; Mol PG
Drug Saf; 2015 Jul; 38(7):621-7. PubMed ID: 26032946
[No Abstract] [Full Text] [Related]
18. Pharmacovigilance in Europe: Place of the Pharmacovigilance Risk Assessment Committee (PRAC) in organisation and decisional processes.
Laroche ML; Batz A; Géniaux H; Féchant C; Merle L; Maison P
Therapie; 2016 Apr; 71(2):161-9. PubMed ID: 27080834
[TBL] [Abstract][Full Text] [Related]
19. Obstacles to transparency over pharmacovigilance data within the EMA.
Prescrire Int; 2015 Nov; 24(165):278-9. PubMed ID: 26688911
[TBL] [Abstract][Full Text] [Related]
20. Safety of fibrinogen concentrate: analysis of more than 27 years of pharmacovigilance data.
Solomon C; Gröner A; Ye J; Pendrak I
Thromb Haemost; 2015 Apr; 113(4):759-71. PubMed ID: 25502954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
